Table 2.
Variables | Univariate | Multivariate | ||||||
---|---|---|---|---|---|---|---|---|
MG-ADL [median (IQR)] | p value | Regression coefficient (95%CI) | p value | |||||
(Intercept) | 1.77 (-0.43, 3.97) | 0.114 | ||||||
Never-smoker | 4 (2-6) | |||||||
Ex-smoker | 4 (2-6) | 0.21 (-0.69, 1.12) | 0.641 | |||||
Current-smoker | 4 (3-5) | 0.825† | 0.22 (-1.01, 1.46) | 0.720 | ||||
Male | 3 (2-6) | |||||||
Female | 4 (3-6) | 0.024 | 0.71 (-0.20, 1.61) | 0.124 | ||||
Age at survey | -0.048‡ | 0.515 | 0.01 (-0.02, 0.03) | 0.697 | ||||
Disease duration (years) | -0.0597‡ | 0.421 | 0.02 (-0.02, 0.06) | 0.322 | ||||
Anti-AChR antibody-negative | 5 (3-7) | |||||||
Anti-AChR antibody-positive | 4 (2-6) | 0.036 | -1.12 (-2.09, -0.15) | 0.024 | ||||
Ocular | 3 (1-4) | |||||||
Generalized | 4 (2-6) | 0.010 | 0.77 (-0.23, 1.77) | 0.129 | ||||
Non-thymoma | 4 (2-6) | |||||||
Thymoma | 4 (2-5) | 0.730 | -0.26 (-1.14, 0.62) | 0.559 | ||||
Without steroid or immunosuppressant | 2 (1-4) | |||||||
With steroid or immunosuppressant | 4 (3-6) | <0.001 | 2.13 (0.94, 3.31) | 0.001 |
MG: myasthenia gravis, ADL: activities of daily living, IQR: interquartile range, CI: confidence interval, AChR: acetylcholine receptor, †p value by Kruskal-Wallis test, ‡Spearman’s rank correlation coefficient